Evaluation of Renal Osteodystrophy and Serum Bone-Related Biomarkers in a Peritoneal Dialysis Population
Autores da FMUP
Participantes de fora da FMUP
- Pereira, L
- Magalhaes, J
- Carvalho, CG
- Oliveira, A
- Beco, A
Unidades de investigação
Abstract
The spectrum of renal osteodystrophy (ROD) in peritoneal dialysis (PD) patients remains to be clarified. Ideal intact parathormone (iPTH) levels range is still not defined. The role of sclerostin, dickkopf-related protein 1, osteoprotegerin, and receptor activator for nuclear factor kappa B ligand for the diagnosis of ROD needs to be elucidated. In this cross-sectional study, tetracycline double-labeled bone biopsy was performed in 49 patients with histomorphometric analysis according Kidney Disease Improving Global Outcomes (KDIGO) guidelines. All patients were treated with biocompatible PD solutions, with calcium concentration of 1.25 mmol/L. Adynamic bone was the most frequent diagnosed pattern (42.9%) followed by hyperparathyroid-related bone disease (28.6%). Twenty-two percent of patients had normal bone. In patients with iPTH within the KDIGO recommended range for dialysis patients, adynamic bone was found in 59% of cases. Median (range) iPTH in patients with adynamic bone was 312 (60-631) pg/mL. Median (range) levels of sclerostin varied from 1511.64 (458.84-6387.70) pg/mL in patients with hyperparathyroid bone disease to 2433.1 (1049.59-11354.52) pg/mL in patients with adynamic bone. Sclerostin/iPTH ratio was the best marker of low turnover disease but iPTH performed best in the diagnosis of high turnover disease. Calcium mass transfer was positive in patients with low bone volume. Adynamic bone is the most frequent ROD pattern in contemporary PD. Our results suggest the need to review the iPTH target range for this population. The sclerostin/iPTH ratio showed improved performance compared to iPTH for the diagnosis of low turnover bone. (c) 2022 American Society for Bone and Mineral Research (ASBMR).
Dados da publicação
- ISSN/ISSNe:
- 1523-4681, 0884-0431
- Tipo:
- Article
- Páginas:
- 1689-1699
- DOI:
- 10.1002/jbmr.4636
- Link para outro recurso:
- www.scopus.com
Journal of Bone and Mineral Research Wiley-Blackwell
Citações Recebidas na Web of Science: 3
Citações Recebidas na Scopus: 9
Documentos
- Não há documentos
Filiações
Keywords
- RENAL OSTEODYSTROPHY; PERITONEAL DIALYSIS; BONE BIOPSY; ADYNAMIC BONE; BONE BIOMARKERS
Proyectos asociados
Update on the impact of sodium-glucose cotransporter inhibitors in diabetic kidney disease progression
Investigador Principal: Ricardo Morais Pereira Neto
Estudo Clínico Académico (Diabetic Kidney) . 2020
Novos Agentes Redutores de Potássio na Abordagem da Hipercalémia na Doença Renal Crónica
Investigador Principal: Ricardo Morais Pereira Neto
Estudo Clínico Académico . 2021
Kidney-induced osteoporosis: a new entity with a novel therapeutic approach.
Investigador Principal: João Miguel Machado Dória Frazão
Estudo Clínico Académico . 2020
Citar a publicação
Pereira L,Magalhaes J,Mendon?a L,Neto R,Santos J,Carvalho CG,Oliveira A,Beco A,Frazao J. Evaluation of Renal Osteodystrophy and Serum Bone-Related Biomarkers in a Peritoneal Dialysis Population. J. Bone Miner. Res. 2022. 37. (9):p. 1689-1699. IF:6,200. (1).